Linde (LIN) Q3 Earnings and Revenues Top Estimates

Linde (LIN) reported Q3 2025 adjusted earnings of $4.21 per share, exceeding the Zacks Consensus Estimate of $4.18, alongside revenues of $8.62 billion, which also surpassed expectations. This marks the fourth consecutive quarter the company has beaten EPS estimates. Despite these positive results, Linde's stock has underperformed the S&P 500 year-to-date, and with a current Zacks Rank #3 (Hold), its near-term performance is anticipated to be in line with the broader market, with investor focus now shifting to management's commentary for future direction.

Analysis

Linde (LIN) reported Q3 2025 adjusted earnings of $4.21 per share, exceeding the Zacks Consensus Estimate of $4.18 and improving from $3.94 a year ago. Revenues for the quarter reached $8.62 billion, also surpassing the consensus estimate of $8.61 billion and growing from $8.36 billion year-over-year. This marks the fourth consecutive quarter Linde has surpassed EPS estimates and the second time in four quarters it has topped revenue forecasts.

Despite these consistent operational beats, Linde's stock has underperformed the broader market, gaining only 2.7% year-to-date compared to the S&P 500's 16% increase. The company currently holds a Zacks Rank #3 (Hold), suggesting its shares are expected to perform in line with the market in the near term. Furthermore, the Chemical - Specialty industry, to which Linde belongs, is ranked in the bottom 39% of Zacks industries, historically underperforming the top half.

The sustainability of the stock's immediate price movement hinges significantly on management's commentary during the earnings call regarding future expectations. While current consensus estimates project Q4 2025 EPS of $4.24 on $8.63 billion in revenues, and full-year EPS of $16.46 on $33.84 billion, the estimate revisions trend for Linde was mixed prior to this report. Investors should closely monitor any changes to these forward-looking estimates.

Key Decisions for Investors

• Investors should prioritize management's commentary on the earnings call for insights into future guidance and potential impacts on stock price movement.
• Evaluate Linde's valuation and growth trajectory in the context of its Zacks Rank #3 (Hold) and the underperforming Chemical - Specialty industry.
• Monitor for changes in consensus earnings estimates for the coming quarters, as these revisions often correlate with near-term stock performance.